Atogepant
3101-312-002
Phase 3 small_molecule active
Quick answer
Atogepant for Chronic or Episodic Migraine (Migraine without aura, migraine with aura, or chronic migraine) is a Phase 3 program (small_molecule) at AbbVie Deutschland GmbH & Co. KG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AbbVie Deutschland GmbH & Co. KG
- Indication
- Chronic or Episodic Migraine (Migraine without aura, migraine with aura, or chronic migraine)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active